AAAAAA
Results:
1-13
|
Results: 13
Authors:
DURANDZALESKI I
EARLAM S
FORDY C
DAVIES M
ALLENMERSH TG
Citation: I. Durandzaleski et al., COST-EFFECTIVENESS OF SYSTEMIC AND REGIONAL CHEMOTHERAPY FOR THE TREATMENT OF PATIENTS WITH UNRESECTABLE COLORECTAL LIVER METASTASES, Cancer, 83(5), 1998, pp. 882-888
Authors:
DAVIES MM
FORDY C
BURKE D
ALLENMERSH TG
Citation: Mm. Davies et al., MANAGEMENT OF SYMPTOMATIC LOCOREGIONAL RECURRENCE DURING REGIONAL CHEMOTHERAPY FOR COLORECTAL LIVER METASTASES, British Journal of Surgery, 85(3), 1998, pp. 364-366
Authors:
FORDY C
GLOVER C
DAVIES MM
ALLENMERSH TG
Citation: C. Fordy et al., HEPATIC ARTERIAL FLOXURIDINE AS 2ND-LINE TREATMENT FOR SYSTEMIC FLUOROURACIL-RESISTANT COLORECTAL LIVER METASTASES, British Journal of Cancer, 78(8), 1998, pp. 1058-1060
Authors:
EARLAM S
GLOVER C
DAVIES M
FORDY C
ALLENMERSH TG
Citation: S. Earlam et al., EFFECT OF REGIONAL AND SYSTEMIC FLUORINATED PYRIMIDINE CHEMOTHERAPY ON QUALITY-OF-LIFE IN COLORECTAL LIVER METASTASIS PATIENTS, Journal of clinical oncology, 15(5), 1997, pp. 2022-2029
Authors:
BURKE D
FORDY C
EARLAM SA
ALLENMERSH TG
Citation: D. Burke et al., HEPATIC ARTERIAL CANNULATION FOR REGIONAL CHEMOTHERAPY IS SAFE IN PATIENTS WITH A LIVER METASTASIS VOLUME OF LESS-THAN 1 LITER, British Journal of Cancer, 75(8), 1997, pp. 1213-1216
Authors:
EARLAM S
GLOVER C
FORDY C
BURKE D
ALLENMERSH TG
Citation: S. Earlam et al., RELATION BETWEEN TUMOR SIZE, QUALITY-OF-LIFE, AND SURVIVAL IN PATIENTS WITH COLORECTAL LIVER METASTASES, Journal of clinical oncology, 14(1), 1996, pp. 171-175
Authors:
JONAS S
WINDEATT S
OBOATENG A
FORDY C
ALLENMERSH TG
Citation: S. Jonas et al., IDENTIFICATION OF CARCINOEMBRYONIC ANTIGEN-PRODUCING CELLS CIRCULATING IN THE BLOOD OF PATIENTS WITH COLORECTAL-CARCINOMA BY REVERSE-TRANSCRIPTASE POLYMERASE CHAIN-REACTION, Gut, 39(5), 1996, pp. 717-721
Authors:
DWORKIN MJ
EARLAM S
FORDY C
ALLENMERSH TG
Citation: Mj. Dworkin et al., IMPORTANCE OF HEPATIC-ARTERY NODE INVOLVEMENT IN PATIENTS WITH COLORECTAL LIVER METASTASES, Journal of Clinical Pathology, 48(3), 1995, pp. 270-272
Authors:
BURKE D
EARLAM S
FORDY C
ALLENMERSH TG
Citation: D. Burke et al., EFFECT OF ABERRANT HEPATIC ARTERIAL ANATOMY ON TUMOR RESPONSE TO HEPATIC-ARTERY INFUSION OF FLOXURIDINE FOR COLORECTAL LIVER METASTASES, British Journal of Surgery, 82(8), 1995, pp. 1098-1100
Authors:
FORDY C
BURKE D
EARLAM S
TWORT P
ALLENMERSH TG
Citation: C. Fordy et al., TREATMENT INTERRUPTIONS AND COMPLICATIONS WITH 2 CONTINUOUS HEPATIC-ARTERY FLOXURIDINE INFUSION SYSTEMS IN COLORECTAL LIVER METASTASES, British Journal of Cancer, 72(4), 1995, pp. 1023-1025
Authors:
DWORKIN MJ
BURKE D
EARLAM S
FORDY C
ALLENMERSH TG
Citation: Mj. Dworkin et al., MEASUREMENT OF RESPONSE TO TREATMENT IN COLORECTAL LIVER METASTASES, British Journal of Cancer, 71(4), 1995, pp. 873-876
Authors:
ALLENMERSH TG
EARLAM S
FORDY C
ABRAMS K
HOUGHTON J
Citation: Tg. Allenmersh et al., QUALITY-OF-LIFE AND SURVIVAL WITH CONTINUOUS HEPATIC-ARTERY FLOXURIDINE INFUSION FOR COLORECTAL LIVER METASTASES, Lancet, 344(8932), 1994, pp. 1255-1260
Authors:
ALLENMERSH TG
EARLAM S
FORDY C
ABRAMS K
HOUGHTON J
Citation: Tg. Allenmersh et al., QUALITY-OF-LIFE AND SURVIVAL WITH CONTINUOUS HEPATIC-ARTERY FLOXURIDINE INFUSION FOR COLORECTAL LIVER METASTASES, Lancet, 344(8932), 1994, pp. 1255-1260
Risultati:
1-13
|